News for Healthier Living

New ALS Drug Stabilizes Decline with a Trend Toward Improved Strength, Mobility for Some

Researchers from Washington University School of Medicine in St. Louis and collaborators report that long-term use of tofersen, a new drug approved by the Food and Drug Administration (FDA) for a genetic form of this deadly illness, delays symptom progression and death and in about one-quarter of participants leads to stabilization or improvement.

December 22, 2025


December 22 2025

December 21 2025

December 20 2025

December 19 2025

December 18 2025

December 17 2025

December 16 2025

December 15 2025

December 14 2025

December 13 2025

December 12 2025

December 11 2025

December 10 2025

December 9 2025